BILL REQ. #:  H-1170.2 

Read first time 01/29/2007.   Referred to Committee on Finance.

     AN ACT Relating to business and occupation tax deduction for chemotherapy and anticancer drugs dispensed pursuant to prescription; and adding a new section to chapter 82.04 RCW.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF WASHINGTON:

NEW SECTION.  Sec. 1   A new section is added to chapter 82.04 RCW to read as follows:
     In computing tax there may be deducted from the measure of tax imposed by RCW 82.04.290(2) amounts received by physicians or clinics for chemotherapy and anticancer drugs for infusion or injection by licensed physicians for human use pursuant to a prescription, but only if the amounts are separately stated on invoices or other billing statements and do not exceed the then current federal rate. The federal rate means the rate at or below which the federal government or its agents reimburse providers for prescription drugs administered to cancer patients as provided for in the medicare, part B, drugs average sales price information resource as published by the United States department of health and human services, or any successor index thereto.